Pulmonary delivery of nano-particles for lung cancer diagnosis and therapy: Recent advances and future prospects

被引：7

作者：

Rong, A. ^{[1
,2
]}

Han, Zhaoguo ^{[1
,2
]}

Wang, Tianyi ^{[1
,2
]}

Zhu, Mengyuan ^{[1
,2
]}

Zhou, Meifang ^{[1
,2
]}

Sun, Xilin ^{[1
,2
]}

机构：

[1] Harbin Med Univ, Hosp 4, Dept Nucl Med, Harbin, Peoples R China

[2] Harbin Med Univ, Mol Imaging Res Ctr MIRC, NHC Key Lab Mol Probe & Targeted Diag & Therapy, Harbin, Peoples R China

来源：

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY | 2024年 / 16卷 / 01期

基金：

中国国家自然科学基金;

关键词：

lung cancer; nano-particles; precision diagnosis and therapy; pulmonary delivery; DRUG-DELIVERY; IN-VIVO; INHALATION TREATMENT; PROMISING STRATEGY; CARBON NANOTUBES; NANOPARTICLES; MICROPARTICLES; NANOTECHNOLOGY; NANOMEDICINE; PROTEIN;

D O I：

10.1002/wnan.1933

中图分类号：

TB3 [工程材料学];

学科分类号：

0805 ; 080502 ;

摘要：

Although our understanding of lung cancer has significantly improved in the past decade, it is still a disease with a high incidence and mortality rate. The key reason is that the efficacy of the therapeutic drugs is limited, mainly due to insufficient doses of drugs delivered to the lungs. To achieve precise lung cancer diagnosis and treatment, nano-particles (NPs) pulmonary delivery techniques have attracted much attention and facilitate the exploration of the potential of those in inhalable NPs targeting tumor lesions. Since the therapeutic research focusing on pulmonary delivery NPs has rapidly developed and evolved substantially, this review will mainly discuss the current developments of pulmonary delivery NPs for precision lung cancer diagnosis and therapy.This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Respiratory Disease Therapeutic Approaches and Drug Discovery > Emerging TechnologiesDiagnostic Tools > In Vivo Nanodiagnostics and Imaging

引用

页数：26